Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood - Wikidata - wikimedia - TriplyDB

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

http://www.wikidata.org/entity/Q34374133

about

Cord Blood as a Source of Natural Killer Cells Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science Alternative Donor Transplantation for Acute Myeloid Leukemia Umbilical cord blood transplantation for the treatment of hematologic malignancies Cord blood graft engineering Which donor or graft source should you choose for the strongest GVL? Is there really any difference Advances in umbilical cord blood manipulation-from niche to bedside Graft-versus-host disease biomarkers: omics and personalized medicine Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?Allogeneic stem cell transplantation in first complete remission Outcomes from unrelated donor hematopoietic stem cell transplantation Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.Umbilical Cord Blood Transplantation: Challenges and Future Directions.Complement fragment 3a priming of umbilical cord blood progenitors: safety profile.Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.Cellular-based therapies to prevent or reduce thrombocytopenia.Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms Engineering cord blood to improve engraftment after cord blood transplant.Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis.Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Cord-Blood Transplantation in Patients with Minimal Residual Disease Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG.).Umbilical cord blood transplantation: the first 25 years and beyond.How closely related is graft-vs-leukemia to donor/recipient disparity?Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.The role and potential of umbilical cord blood in an era of new therapies: a review The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation Concise review: umbilical cord blood transplantation: past, present, and future High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?How I treat: the selection and acquisition of unrelated cord blood grafts.

P2860

Q26771337-6888B9CA-90F1-421B-BBE2-76FA55F5E173 Q26772216-5AEC628E-9D83-4694-A294-4E52E27C76B7 Q26781919-9B0FDE69-A6A7-4096-A212-58711D3D00B3 Q26799456-54A8D6E8-82E8-45B4-B301-849EEEAF2ABF Q26820829-0D19D1CA-2D8E-459C-B315-A108A5A6E93A Q26822376-8D03A15B-1BCB-444A-BD1F-69986E2603CA Q26823536-95EF462B-CB0C-4DE9-BCFD-8D35F3CB0FA2 Q26824305-8DA11202-0432-42BB-8FBD-9E11A89E450C Q26824540-936BA082-8AB4-41B5-9069-E0DF488DE2A4 Q26830857-BF478E52-D7DD-4ABF-96D7-5D59C5271342 Q26996818-2FEC611C-A9CB-42B9-882B-6C75D52EA123 Q27027854-3A68F67F-EC50-4C1E-8B70-0A7EECC95A9A Q28080943-34CEC56E-B61C-4B36-B881-6D258322B51F Q30252975-31357AA8-48CC-4D36-B11D-D2F09EF04D5D Q30352323-99B89AB6-EBA2-44C3-B863-0155A28F8752 Q30366297-400E1C42-BF8D-46FC-9247-46D928B1DCE3 Q30415126-AF3741F0-3464-45DA-91C6-24086B5945E4 Q30423085-B159F08D-E0C7-46DA-87D2-C85958E93F01 Q33398164-D455798E-8FC9-45B3-9055-818AD4671823 Q33456839-1F2BDD80-430E-424C-A8FC-41536C4A0C40 Q33705051-30F0E211-FC6E-440A-8320-6E814CB474F9 Q33766995-41CBBBED-73E7-400D-B235-A2CB5F8BC31B Q33774504-9FDAC583-1490-443D-98F5-31266D70C62F Q33783183-C07B721E-3F28-4C0B-83D2-651D495E2692 Q33808209-56F23067-96D8-4FE1-98CD-2B058A6D0C7A Q33820379-46D3DAAD-9EF7-4712-8CA3-02F042698741 Q33897804-21761AF1-962A-4D8C-BF50-C350288DE61D Q33911314-A023A478-BF0B-4C15-9DBB-7A94FDB0AC8C Q34033553-2F36314E-54AA-4582-9290-A189F4929039 Q34175568-5D5F4C85-0201-4465-B7C0-B2CFF743E4E6 Q34232835-CCA10FBD-B1D5-41CB-94F0-C9F7DE5E08A6 Q34315848-B982C2FB-795E-4353-B3A4-72F55803A489 Q34344669-30E99334-6CBB-44C2-8CC6-A917672794A0 Q34412313-086D0C2D-EAA1-4B41-AAB6-DCE25055F7F1 Q34463602-2EBA06D0-F1AC-45E7-868B-839E07E6FCDC Q34483172-009D7ACB-FC75-4937-9E8C-49CC1FEA8DB2 Q34551183-1C7455ED-6C2A-45A9-891B-C6EBF3B95699 Q34601968-DA99E58F-3ABA-4281-B621-634BBFBCC0AD Q34645259-20A52286-D3D4-42C3-9FAE-A74A4712B3B6 Q34707580-0FE9FEAE-99E8-4382-BAA7-A7768BBF753E

P2860

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

http://www.wikidata.org/entity/Q34374133

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@ast

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@en

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@nl

type

label

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@ast

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@en

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@nl

prefLabel

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@ast

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@en

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@nl

P1433

Q34374133-B73DE61A-1A86-47C4-8E8A-5A263A53A56C

P1476

Q34374133-E27CFB3B-D14A-4259-85EF-B1E4258D5409

P2093

Q34374133-0D463DF8-EB17-464F-8138-DF1345B4CF23

Q34374133-1976961C-C35A-4DBE-A7A8-C43DB2828709

Q34374133-234C5D04-D6ED-43C9-975A-A0BD71DCA890

Q34374133-62656B6D-18F5-45C4-B745-F9B032E824E9

Q34374133-8FF6A88A-D3E0-4225-8674-C97AEB4543BC

Q34374133-BE2F15F9-FE91-4B20-80D8-61DF9D799677

Q34374133-BFA65153-1D65-4DD4-AE97-3BE3B721189B

Q34374133-E2923BD1-AF19-4C6E-A5B2-81CF58B01283

Q34374133-FB2D85E1-BA27-4219-AE3D-8C3DB4E481A9

P2860

Q34374133-00387330-5E08-48E2-A1FE-DED8B417073C

Q34374133-04E23ADB-873B-44E5-AF07-F1E73EDD5E10

Q34374133-1BB6C3E5-097E-4537-9003-C3D3D2B87603

Q34374133-2B1FEB4F-65DC-430A-BCAF-9EE1532A0EB8

Q34374133-3017C838-8C61-4243-A9A5-8610D8BA1094

Q34374133-3618009B-7C34-4D57-95D7-B6569DDE93F0

Q34374133-41D7EC0D-C086-4028-984C-16BDAEBF6D5E

Q34374133-421031CB-BDCA-4D78-A195-3F51EBA58D02

Q34374133-5B2CE329-3522-41F8-A261-8F7D6CB72ACF

Q34374133-8BB762EC-B624-4341-A0FC-F69791F26BE3

P304

Q34374133-AA74BEDE-28B8-4282-8CCB-AF1C5518E247

P31

Q34374133-93C90DC9-53B9-41F5-AFC7-3E9F9B4C0DD2

P356

Q34374133-B8C5B302-34A4-46E5-9F4D-8059880F86D7

P407

Q34374133-9B1A5909-E192-4384-B22F-97ACB5CAB11C

P433

Q34374133-7B376D37-0C12-4CBC-AF1B-EE7E203C2209

P478

Q34374133-D86DB2EE-685F-43D3-BDF0-F74B7FFD474A

P50

Q34374133-F37D5BAC-02E7-4CD2-9F6D-200918F10B42

P577

Q34374133-21E1060D-66DC-40D7-AEE7-413C1B90E78D

P5875

Q34374133-4A1C2A70-3505-4DA0-9C26-479A9D0A2470

P698

Q34374133-E2E74A0A-8005-4DD6-9B66-88E668BD449E

P932

Q34374133-762070AA-1BB6-4C8D-93F8-1CFD6F5239CD

P356

BLOOD-2010-05-285304

P1433

P1476

Allogeneic hematopoietic cell ...... of double umbilical cord blood

@en

P2093

Ann E Woolfrey

http://www.w3.org/2001/XMLSchema#string

Claudio G Brunstein

http://www.w3.org/2001/XMLSchema#string

Colleen Delaney

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

John E Wagner

http://www.w3.org/2001/XMLSchema#string

Jonathan A Gutman

http://www.w3.org/2001/XMLSchema#string

Michael R Verneris

http://www.w3.org/2001/XMLSchema#string

Theodore A Gooley

http://www.w3.org/2001/XMLSchema#string

Todd E Defor

http://www.w3.org/2001/XMLSchema#string

P2860

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Double unrelated reduced-intensity umbilical cord blood transplantation in adults.

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

P304

4693-4699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-05-285304

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Frederick R. Appelbaum

P577

2010-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45505520

http://www.w3.org/2001/XMLSchema#string

P698

20686119

http://www.w3.org/2001/XMLSchema#string

P932

2996124

http://www.w3.org/2001/XMLSchema#string